Published in Cancer on October 01, 1975
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
A multi-institutional phase II study of the efficacy and tolerability of lapatinib in patients with advanced hepatocellular carcinomas. Clin Cancer Res (2009) 1.04
Current management of advanced hepatocellular carcinoma. Gastrointest Cancer Res (2008) 1.04
Surgical strategy for liver cancers in the era of effective chemotherapy. Liver Cancer (2013) 0.84
Spontaneous regression of hepatocellular carcinoma. Gut (1990) 0.83
Clinical efficacy and toxicity of standard dose adriamycin in hyperbilirubinaemic patients with hepatocellular carcinoma: relation to liver tests and pharmacokinetic parameters. Br J Cancer (1992) 0.80
Hepatitis B virus and HIV infection among patients with primary hepatocellular carcinoma in Kampala, Uganda. Afr Health Sci (2011) 0.79
Recombinant leukocyte interferon, doxorubicin, and 5FUDR in patients with hepatocellular carcinoma-A phase II trial. J Cancer Res Clin Oncol (2003) 0.78
Systemic therapy in hepatocellular carcinoma. Clin Liver Dis (2011) 0.78
Combined cis-platinum and alpha interferon therapy of advanced hepatocellular carcinoma. Korean J Intern Med (1996) 0.77
Interventional radiological treatment of hepatocellular carcinoma: an update. Indian J Surg (2011) 0.76
Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol (1992) 0.76
Transcatheter arterial chemoembolization for hepatocellular carcinoma. Cancer Chemother Pharmacol (1989) 0.76
Hepatic resection in primary liver carcinoma: prolonged survival in two Nigerian patients. J Natl Med Assoc (1982) 0.75
Update in cancer chemotherapy: gastrointestinal cancer, cancer of the small intestines, gallbladder, liver, and esophagus. J Natl Med Assoc (1986) 0.75
Hepatocellular carcinoma- etiologic considerations: a review of the literature. J Natl Med Assoc (1981) 0.75
Hepatocellular carcinoma (HCC): beyond sorafenib-chemotherapy. J Gastrointest Oncol (2017) 0.75
Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy. Diseases (2015) 0.75
Systemic treatment of hepatocellular carcinoma: Past, present and future. World J Hepatol (2017) 0.75
Helicobacter pylori. Clin Microbiol Rev (1997) 9.22
Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med (1989) 5.78
Systematic review of long term anticoagulation or antiplatelet treatment in patients with non-rheumatic atrial fibrillation. BMJ (2001) 5.77
The clinical significance of Campylobacter pylori. Ann Intern Med (1988) 5.08
Dietary sodium intake and mortality: the National Health and Nutrition Examination Survey (NHANES I). Lancet (1998) 5.02
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Pancreatic and duodenal homeobox gene 1 induces expression of insulin genes in liver and ameliorates streptozotocin-induced hyperglycemia. Nat Med (2000) 3.96
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (1987) 3.78
Renal function during antihypertensive treatment. Lancet (1995) 3.33
Critical care delivery in the intensive care unit: defining clinical roles and the best practice model. Crit Care Med (2001) 2.76
AIDS and self-organization among intravenous drug users. Int J Addict (1987) 2.73
Percutaneous coronary intervention in the current era compared with 1985-1986: the National Heart, Lung, and Blood Institute Registries. Circulation (2000) 2.65
Helicobacter pylori infection in pernicious anemia: a prospective controlled study. Gastroenterology (1991) 2.57
Anticoagulation in patients with atrial fibrillation. GPs not prepared for monitoring anticoagulation. BMJ (1993) 2.49
Hematological reference ranges among healthy Ugandans. Clin Diagn Lab Immunol (1995) 2.44
Serum uric acid and cardiovascular events in successfully treated hypertensive patients. Hypertension (1999) 2.44
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction. Hypertension (1994) 2.35
Serious hazards of transfusion (SHOT) initiative: analysis of the first two annual reports. BMJ (1999) 2.31
ERCC1 mRNA levels complement thymidylate synthase mRNA levels in predicting response and survival for gastric cancer patients receiving combination cisplatin and fluorouracil chemotherapy. J Clin Oncol (1998) 2.26
Guidelines for the clinical use of red cell transfusions. Br J Haematol (2001) 2.21
Thymidylate synthase mRNA level in adenocarcinoma of the stomach: a predictor for primary tumor response and overall survival. J Clin Oncol (1996) 2.21
Prevention of blinking alters iris configuration in pigment dispersion syndrome and in normal eyes. Ophthalmology (1995) 2.21
Errors in anti-D immunoglobulin administration: retrospective analysis of 15 years of reports to the UK confidential haemovigilance scheme. BJOG (2013) 2.16
Guidelines on the investigation and management of the antiphospholipid syndrome. Br J Haematol (2000) 2.14
Craniopharyngiomas: a clinicopathological analysis of factors predictive of recurrence and functional outcome. Neurosurgery (1994) 2.13
Comment of N.O.P.H.N. Field Staff on Seattle and Richmond Reports. Am J Public Health Nations Health (1948) 2.06
Kaposi's sarcoma in Uganda: a clinico-pathological study. Int J Cancer (1971) 2.06
Methods for managing the increased workload in anticoagulant clinics. BMJ (1996) 2.03
MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci (1993) 1.97
Outcome of MDR-TB patients, 1983-1993. Prolonged survival with appropriate therapy. Am J Respir Crit Care Med (1996) 1.88
Choledocholithiasis. Endoscopic sphincterotomy or common bile duct exploration. Ann Surg (1991) 1.88
Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its components. J Clin Invest (1995) 1.85
Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes. Brain Pathol (1998) 1.84
Diuretic induced hyponatraemia in elderly hypertensive women. J Hum Hypertens (2002) 1.81
Botulinum toxin treatment of spasmodic torticollis. J R Soc Med (1992) 1.81
Helicobacter pylori in developing countries. World Gastroenterology Organisation Global Guideline. J Gastrointestin Liver Dis (2011) 1.80
Purification and characterization of human plasma glutathione peroxidase: a selenoglycoprotein distinct from the known cellular enzyme. Arch Biochem Biophys (1987) 1.73
Prevention of diabetes in NOD mice treated with antibody to murine IFN gamma. J Autoimmun (1991) 1.71
Optimal management of the pancreatic remnant after pancreaticoduodenectomy. Ann Surg (1995) 1.71
Evaluation of a nurse specialist anticoagulant service. Clin Lab Haematol (1997) 1.66
Treatment-induced blood pressure reduction and the risk of myocardial infarction. JAMA (1989) 1.64
Transfusion guidelines for neonates and older children. Br J Haematol (2004) 1.61
A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry (1998) 1.60
Development of AIDS, HIV seroconversion, and potential co-factors for T4 cell loss in a cohort of intravenous drug users. AIDS (1987) 1.60
Effect of long-acting and short-acting calcium antagonists on cardiovascular outcomes in hypertensive patients. Lancet (1997) 1.60
General practitioners' and patients' models of obesity: whose problem is it? Patient Educ Couns (2001) 1.59
The anticardiolipin assay is required for sensitive screening for antiphospholipid antibodies. J Thromb Haemost (2004) 1.56
Diabetes mellitus in the aetiology of Dupuytren's disease. J Bone Joint Surg Br (1984) 1.55
Frequent presence of a novel herpesvirus genome in lesions of human immunodeficiency virus-negative Kaposi's sarcoma. J Infect Dis (1996) 1.53
Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer (1994) 1.52
Transmitted antiretroviral drug resistance surveillance among newly HIV type 1-diagnosed women attending an antenatal clinic in Entebbe, Uganda. AIDS Res Hum Retroviruses (2008) 1.51
Measurement of ultrasound biomicroscopy images: intraobserver and interobserver reliability. Invest Ophthalmol Vis Sci (1994) 1.50
Guidelines for anticoagulation. BMJ (1994) 1.50
Audit of start of anticoagulation treatment in inpatients. J Clin Pathol (1993) 1.49
Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. Am J Pathol (1997) 1.49
The determinants of hypertension awareness, treatment, and control in an insured population. Am J Public Health (1994) 1.48
Prevalence of gastric metaplasia, inflammation, and Campylobacter pylori in the duodenum of members of a normal population. Am J Clin Pathol (1988) 1.47
Immunological studies in Kaposi's sarcoma in Uganda. Br Med J (1970) 1.47
The Serious Hazards of Transfusion (SHOT) initiative: the UK approach to haemovigilance. Vox Sang (2000) 1.45
Influence of proteinuria on vascular disease, blood pressure, and lipoproteins in insulin dependent diabetes mellitus. Br Med J (Clin Res Ed) (1987) 1.44
A painful train of events: increased prevalence of fibromyalgia in survivors of a major train crash. Clin Exp Rheumatol (2010) 1.43
Lack of effect of granulocyte-macrophage and granulocyte colony-stimulating factors on cultured human endothelial cells. Blood (1991) 1.43
A fatal pulmonary complication of lupus in pregnancy. Arthritis Rheum (1995) 1.42
[Latin-American consensus document on irritable bowel syndrome]. Gastroenterol Hepatol (2004) 1.42
Natural history of left ventricular function during 1 year after acute myocardial infarction: comparison with clinical, electrocardiographic and biochemical determinations. Am J Cardiol (1980) 1.42
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens (1997) 1.41
Low serum cobalamin levels occur frequently in the acquired immune deficiency syndrome and related disorders. Eur J Haematol (1987) 1.41
The lipofuscin-iron association in pigmentosis tubae. Ultrastruct Pathol (1997) 1.38
Treating syphilis effectively. Nurse Pract (2000) 1.37
Gynecomastia and gonadal dysfunction in adolescent boys treated with combination chemotherapy for Hodgkin's disease. N Engl J Med (1978) 1.35
Immune response of mice to ingested Toxoplasma gondii: a model of toxoplasma infection acquired by ingestion. J Infect Dis (1984) 1.35
Kaposi's sarcoma in childhood: an analysis of 100 cases from Uganda and relationship to HIV infection. Int J Cancer (1996) 1.34
Blue rubber bleb nevus syndrome presenting with recurrences. Dig Dis Sci (1987) 1.32
Prospective comparison of commercially available rapid urease tests for the diagnosis of Helicobacter pylori. Gastrointest Endosc (1996) 1.30
Thoracic actinomycosis in childhood. Clin Pediatr (Phila) (1985) 1.30
Treatment of Burkitt's tumor with cyclophosphamide. Cancer (1970) 1.29
Xanthogranulomatous appendicitis--an incidental finding of localized pathology. Ultrastruct Pathol (2000) 1.28
Prospective comparison of H&E, Giemsa, and Genta stains for the diagnosis of Helicobacter pylori. Gastrointest Endosc (1997) 1.27
Carcinoma of the penis. A review of 153 patients admitted to Mulago Hospital, Kampala, Uganda. East Afr Med J (1966) 1.27
Kaposi's sarcoma. IV. Detection of CMV DNA, CMV RNA and CMNA in tumor biopsies. Int J Cancer (1981) 1.26
Evaluation of patients' knowledge about anticoagulant treatment. Qual Health Care (1994) 1.26
Migration of brain tumor cells on extracellular matrix proteins in vitro correlates with tumor type and grade and involves alphaV and beta1 integrins. Cancer Res (1996) 1.26
Avoiding the misuse of fresh frozen plasma. BMJ (1993) 1.25
Changes in the practice of percutaneous coronary intervention: a comparison of enrollment waves in the National Heart, Lung, and Blood Institute (NHLBI) Dynamic Registry. Am J Cardiol (2001) 1.25
Ectopic pancreas presenting as a submucosal gastric antral tumor that was cystic on EUS. Gastrointest Endosc (2001) 1.24
Animal models of depression and anxiety: What do they tell us about human condition? Prog Neuropsychopharmacol Biol Psychiatry (2010) 1.23
The role of motor evoked potentials during surgery for intramedullary spinal cord tumors. Neurosurgery (1997) 1.21
Risk factors for Kaposi's sarcoma in HIV-positive subjects in Uganda. AIDS (1997) 1.21
The changing world of group health insurance. Health Aff (Millwood) (1988) 1.20
Prevalence of antibody to lymphadenopathy-associated virus among drug-detoxification patients in New York. N Engl J Med (1984) 1.19
Ethical, behavioral, and social aspects of HIV vaccine trials in developing countries. JAMA (1994) 1.19
Advanced heart block as a complication of acute myocardial infarction. Role of pacemaker therapy. Prog Cardiovasc Dis (1968) 1.19
Neurometer measurement of current stimulus threshold in rats. J Pharmacol Exp Ther (2001) 1.18
Human papillomavirus (HPV) DNA in penile carcinomas and in two cell lines from high-incidence areas for genital cancers in Africa. Int J Cancer (1992) 1.18
Cachectin/tumor necrosis factor-alpha alters red blood cell kinetics and induces anemia in vivo. FASEB J (1989) 1.17
Treatment of Kaposi's sarcoma with actinomycin-D and cyclophosphamide: results of a randomized clinical trial. Int J Cancer (1971) 1.16
UK Transfusion Laboratory Collaborative: recommended minimum standards for hospital transfusion laboratories. Transfus Med (2009) 1.16